An eight-year study of 3,496 rare disease hospitalizations at a tertiary hospital in northern Henan reveals rising admission numbers, heavy nervous system and respiratory disease burdens, and substantial costs that peak for perinatal and tumor-related conditions.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.